Asuragen Armored RNA Quant Zika Virus Control | GenomeWeb

Asuragen Armored RNA Quant Zika Virus Control

Aug 10, 2016

Asuragen has launched its custom Armored RNA Quant Zika Virus target, which can be used to develop molecular assays. The company's Armored RNA Quant technology is the gold standard for reliable and traceable standards to develop molecular assays for virus quantitation, the company said. Developed in collaboration with Jan Felix Drexler, professor at the University of Bonn Medical Center and the German Center for Infection Research, the control is a multi-gene target designed using seven genes from the Zika Brazilian reference sequence KU321639.

More Like This

Oct 26, 2016

DEPArray OncoSeek Panel And DEPArray LibPrep Kit

Menarini-Silicon Biosystems and Swift Biosciences have collaborated to develop and launch the DEPArray OncoSeek Panel and the DEPArray LibPrep Kit. Both products were developed to prepare and analyze tumor cells derived from formalin-fixed, paraffin-embedded tissue samples. The LibPrep kit will allow researchers to build complex NGS libraries from a few hundred FFPE cells that contain low amounts of damaged and fragmented DNA, the company said. The OncoSeek panel will allow simultaneous analysis of sequence variants and copy number alterations focused on cancer-associated genes, and employs a streamlined single tube 2-hour reaction, generating reliable ready-to-sequence Illumina-compatible libraries, the company said.

Oct 26, 2016

PerkinElmer NEXTflex Custom Amplicon Panels

PerkinElmer has launched several new NEXTflex Custom Amplicon panels.The panels analyze BRCA1/2, CEBPA, HBOC-3, MEFV, TP53, and specific genes related to colon cancer, diabetes, and nephrotic syndrome. They can also detect somatic mutations in BRCA1/2 and TP53 loci. The panels offer a cost-effective solution for on-target reads with 100 percent coverage of targeted regions, the company said.

Oct 26, 2016

Personal Genome Diagnostics RNAcomplete

Personal Genome Diagnostics has launched RNAcomplete, a new testing service that allows researchers to co-extract total RNA and genomic DNA from a single tissue sample. The testing service uses RNA-seq to analyze gene transcripts corresponding to more than 34,000 genes and 84,000 transcript isoforms. It has been optimized for maximum performance using FFPE tissue and employs a macrodissection process for improved sensitivity and specificity, the company said.

Oct 21, 2016

Arcis DNA Blood Kit

Arcis Biotechnology has launched the Arcis DNA Blood Kit (IVD). The kit uses a three minute two step system to prepare DNA from fresh or frozen whole blood samples for use in in vitro diagnostic applications. It is also suitable to extract DNA from specimens stored in ethylenediaminetetraacetic acid and heparin-containing solutions. The product is non-hazardous, and both ships and stores at room temperature for ease of handling, the company said.

Oct 20, 2016

Qiagen QIAscout for Single-Cell Isolation

Qiagen has launched QIAscout, a novel instrument for isolation of of viable single cells from samples for downstream applications. It uses the company's technology includes a high-density array with 12.000 microcrafts that can be used to isolate and recover individual cells from a cell suspension. QIAscout works with standard inverted microscopes to reliably select and release isolated single cells. The instrument is the size of a hand-held mobile device.

Oct 20, 2016

Agilent SureGuide CRISPR Libraries for Functional Genomics

Agilent Technologies has launched new CRISPR/Cas9 guide RNA (gRNA) libraries for pooled screening. Agilent is offering both genome-scale CRISPR knockout (GeCKO) and customized SureGuide gRNA libraries for functional genomics in three varieties: ready-to-package GeCKO plasmid libraries, ready-to-clone custom libraries that can be prepared for delivery with SureVector cloning kits, and ready-to-amplify custom libraries for total control over library design.

Oct 19, 2016

SeraCare Seraseq Inherited Cardiomyopathy Reference Material

SeraCare Life Sciences has launched the Seraseq Inherited Cardiomyopathy Reference Material, a multiplexed reference material for hypertrophic cardiomyopathy (HCM) testing by next-generation sequencing. It was developed in collaboration with Birgit Funke, director of clinical research and development at the Partners Healthcare Laboratory for Molecular Medicine. The Seraseq reference material combines ten common pathogenic and/or technically challenging variants for HCM in a well characterized genomic background at a 50 percent target allele frequency, the company said. This is the first testing  control product to be launched after the company's research on testing controls was published online in the Journal of Molecular Diagnostics earlier this year.

Oct 19, 2016

NanoString NCounter Vantage 3D Panels

NanoString Technologies has launched two new translational research assays, nCounter Vantage 3D DNA (SNV) Solid Tumor panel and nCounter Vantage 3D Protein Solid Tumor Signaling Pathways panel. The nCounter Vantage 3D DNA (SNV) Solid Tumor panel is designed for highly multiplexed profiling of known cancer mutations, as well as insertion and deletions from as little as five nanograms of DNA, while the nCounter Vantage 3D Solid Tumor Signaling Pathways panel enables the identification of activation state through the measurement of total proteins and phosphoproteins from a single slice of FFPE tissue or form as little as 250 ng of protein from cell or tissue lysate. The two new panels can be combined with one another as well as with the nCounter Vantage RNA panels to enable more comprehensive profiling of formalin-fixed, paraffin embedded tumor tissue.

Oct 19, 2016

Qiagen QIAseq cfDNA All-in-One Kit

Qiagen has launched the QIAseq cfDNA All-in-One kit, which combines cell-free DNA extraction and library preparation in the first dedicated solution for liquid biopsy analysis on any next-generation sequencing platform. The kit builds on the company's QIAamp technology and integrates the company's recently launched PAXgene Blood ccfDNA tube for collection and stabilization of blood samples. It creates a streamlined testing solution that allows faster, more convenient, and reliable analysis of cell-free DNA from sample collection to interpreted result, the company said.

Oct 19, 2016

Zymo Quick-cfRNA Serum and Plasma Kit

Zymo Research has launched the Quick-cfRNA Serum and Plasma kit. The kit uses the company's Zymo-Spin technology to purify cell-free RNA from up to one ml of plasma, serum, or other biological fluids. The kit produces isolated RNA immediately ready for sensitive downstream applications including RT-qPCR and next-generation sequencing. It can also be used for biomarker discovery and advanced liquid biopsy research, the company said.

Oct 19, 2016

Sygnis CovCheck Kit

Sygnis has launched the CovCheck kit, a PCR-based kit for whole genome amplification coverage to determine the quality and integrity of the amplified DNA. The kit includes 24 different sets of primer pairs each targeting a specific human chromosome and has a 96-well plate format. The product shows a strong correlation between the samples amplified and the real coverage obtained through whole genome sequencing, the company said.

Oct 19, 2016

Cambridge Epigenetix TrueMethyl Whole Genome

Cambridge Epigenetix has launched the TrueMethyl Whole Genome, an integrated workflow for processing DNA samples and epigenetic analysis. The kit incorporates the company's TrueMethyl oxidative bisulfite technology, which allows researchers to accurately quantify different DNA modifications at single-base resolution, and proprietary library preparation methods. The kit also incorporates bioinformatic tools comprised of a series of scripts for QC analysis and biological analysis of the resultant sequencing data.

Oct 19, 2016

10X Genomics Chromium Single Cell Controller

10X Genomics has launched the Chromium Single Cell Controller, a massively scalable tool for comprehensive single cell analysis. The instrument can interrogate hundreds to millions of cells, and features a simple and comprehensive workflow which enables users to quickly and easily prepare single cell sequencing libraries in less than one workday, the company said. Additionally, the instrument includes an easy-to-use software suite for rapid analysis and visualization of very large single cell datasets. It can also support a variety of applications, including the existing Chromium Single Cell 3' Solution for single cell transcriptomics. The system is accompanied by Chromium Single Cell 3' reagent kits and features full compatibility with Illumina HiSeq, NextSeq and MiSeq sequencers. It's currently available at an introductory price of $50,000.

Oct 18, 2016

Igenbio's Metagenomics Application

Igenbio has added a new module for analyzing metagenomic data to its ERGO software platform. The module lets users explore phylogenetic hierarchies, metabolic potential, as well as transcriptomic data to discover expression dynamics between samples, treatments, and conditions.

Oct 18, 2016

Genalice Map 2.4.0

Genalice has released Genalice 2.4.0, the latest iteration of of its software for secondary analysis of next-generation sequencing data. This release includes a new somatic calling module that helps users distinguish between variants found in normal and tumor tissue samples. According to the company, the new module outperforms existing tools such as MuTecT, FreeBayes, and VarScan in terms of both speed and accuracy. Other updates to the software include a tool that lets users create profiles for defined cohorts for targeted cell amplification and suppression as well as a tool for detecting copy number variants.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.

Sponsored by

This webinar will discuss a partnership model for noninvasive prenatal testing that enabled LifeLabs Genetics, a genetic testing lab based in Toronto, Ontario, to implement NIPT in house.